NDC 0056-0510

SUSTIVA

Efavirenz

SUSTIVA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bristol-myers Squibb Pharma Company. The primary component is Efavirenz.

Product ID0056-0510_092e0b1d-a576-4e96-bc9b-8d3f43cbb2df
NDC0056-0510
Product TypeHuman Prescription Drug
Proprietary NameSUSTIVA
Generic NameEfavirenz
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2002-01-02
Marketing CategoryNDA / NDA
Application NumberNDA021360
Labeler NameBristol-Myers Squibb Pharma Company
Substance NameEFAVIRENZ
Active Ingredient Strength600 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0056-0510-30

30 TABLET, FILM COATED in 1 BOTTLE (0056-0510-30)
Marketing Start Date2002-01-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0056-0510-30 [00056051030]

SUSTIVA TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021360
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-01-02

Drug Details

Active Ingredients

IngredientStrength
EFAVIRENZ600 mg/1

OpenFDA Data

SPL SET ID:32d6371e-ba56-4294-b732-6d43627c5c47
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349477
  • 352143
  • 205292
  • 205290
  • 213390
  • 213392
  • UPC Code
  • 0300560474922
  • 0300560510309
  • 0300560470306
  • Pharmacological Class

    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]

    NDC Crossover Matching brand name "SUSTIVA" or generic name "Efavirenz"

    NDCBrand NameGeneric Name
    0056-0470SUSTIVAEfavirenz
    0056-0474SUSTIVAefavirenz
    0056-0510SUSTIVAefavirenz
    70518-0482SUSTIVASUSTIVA
    0378-2233Efavirenzefavirenz
    31722-504EfavirenzEfavirenz
    42543-889EfavirenzEfavirenz
    51407-382EfavirenzEfavirenz
    64380-889EfavirenzEfavirenz
    64980-406EfavirenzEfavirenz
    64980-407EfavirenzEfavirenz
    65862-049EfavirenzEfavirenz
    65862-104EfavirenzEfavirenz

    Trademark Results [SUSTIVA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SUSTIVA
    SUSTIVA
    77584955 4179689 Dead/Cancelled
    Bristol-Myers Squibb Pharma Company
    2008-10-03
    SUSTIVA
    SUSTIVA
    75548410 not registered Dead/Abandoned
    DuPont Pharmaceuticals Company
    1998-09-04
    SUSTIVA
    SUSTIVA
    75240870 2496476 Live/Registered
    BRISTOL-MYERS SQUIBB PHARMA COMPANY
    1997-02-12

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.